Restoring Inspection Readiness and Data Integrity Following a CRO Transition
A CRO transition can uncover critical gaps in clinical trial oversight, documentation, protocol deviation management, and inspection readiness. When monitoring records are incomplete and outstanding compliance issues remain unresolved, sponsors need to act quickly to protect data integrity and restore confidence in study quality.In this case study, discover how ProPharma supported CRO transitions, using a comprehensive remediation strategy that combined risk assessment, targeted remonitoring, protocol deviation reconciliation, and structured eTMF and investigator site file remediation.
Download the case study to learn how ProPharma helped restore monitoring oversight, achieve audit-ready TMF status within 12 weeks, increase inspection readiness by more than 50%, and achieve 100% capture of known protocol deviations, establishing sustainable quality oversight and restoring confidence in study data.
Case Study
Related Resources
Infographic
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
Infographic
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
Infographic
Navigating the Generic Drug Application and Approval Process
Navigating the generic drug application and approval process can be challenging. From pre-filing through post-approval, find out exactly what needs to be done for your Abbreviated New Drug...